Although the retrospective evidence demonstrates TLSs have better predictive value than PD-L1 in early breast cancer patients treated with ICIs, it also underscores the need for prospective studies to validate and fully comprehend the impact of spatial distribution on prognosis. This evidence concerns the gene CD274 and breast cancer.